Menitrazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401512This classification denotes a benzodiazepine with the molecular formula C16H17N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1243654WZK, chemically known as 2h-1,4-benzodiazepin-2-one, 5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-7-nitro- but generally known as menitrazepam, which bears US NIH Compound Identifier 189875. European Medicines Agency schedules Menitrazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08740MIG. The term MENITRAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). MENITRAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule menitrazepam under HS 29339940 and SITC 51577. As of Q4 2014, MENITRAZEPAM remains the US FDA Preferred Term for this commodity. Menitrazepam bears US NLM identifiers UMLS ID C1881782 and NCI Concept Code C66088. SMILES: O=C1N(C2C(C(=NC1)C1=CCCCC1)CC([N](=O)O)CC2)C.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.